Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases | Cardiology/Vascular Diseases | Hepatology (Liver, Pancreatic, Gall Bladder) | Genetic Disease
Cystic Fibrosis Clinical Trials
A listing of Cystic Fibrosis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 5 6 7 8 9 10 11 12 13 Last
Alabama
Birmingham Alabama
A clinical study for patients with Cystic Fibrosis
Birmingham Alabama
A clinical research study of Ivacaftor for the treatment of Cystic Fibrosis
Birmingham Alabama
A clinical research study of Lumacaftor and Ivacaftor for the treatment of Cystic Fibrosis
University of Alabama
Birmingham Alabama 35294Updated
A clinical research study of N6022 and Normal saline for the treatment of Cystic Fibrosis
Site Reference ID/Investigator# 78920
Birmingham Alabama 35233
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
View More »
University of Alabama at Birmingham
Birmingham Alabama 35233Updated
A clinical trial to evaluate treatments using Aztreonam for Inhalation Solution (AZLI) and Placebo for patients with Cystic Fibrosis
Birmingham Alabama
A clinical trial to evaluate treatments using ivacaftor for patients with Cystic Fibrosis
Birmingham Alabama
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Vertex Investigational Site
Birmingham Alabama
A clinical trial to evaluate treatments using VX-661, VX-770, VX-661 placebo and VX-770 placebo for patients with Cystic Fibrosis
Birmingham Alabama Updated
Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation
Mobile Alabama 36608
Patients are needed to participate in a clinical research study evaluating KB001-A and Placebo Comparator for the treatment of Cystic Fibrosis
Alaska
Providence Alaska Medical Center
Anchorage Alaska 99508Updated
A clinical research study of N6022 and Normal saline for the treatment of Cystic Fibrosis
Site Reference ID/Investigator# 116382
Anchorage Alaska 99508
A clinical trial seeking patients for a research study for the treatment of Cystic Fibrosis
Site Reference ID/Investigator# 79256
Anchorage Alaska 99508
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Anchorage Alaska
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Anchorage Alaska Updated
Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation
Arizona
Site Reference ID/Investigator# 78906
Phoenix Arizona 85016
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Phoenix Children's Hospital
Phoenix Arizona 85016Updated
A clinical trial to evaluate treatments using Aztreonam for Inhalation Solution (AZLI) and Placebo for patients with Cystic Fibrosis
Phoenix Arizona 85016
Patients are needed to participate in a clinical research study evaluating KB001-A and Placebo Comparator for the treatment of Cystic Fibrosis
Site Reference ID/Investigator# 78939
Tucson Arizona 85724
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Tucson Arizona
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
View More »
Tucson Arizona 85724
Patients are needed to participate in a clinical research study evaluating KB001-A and Placebo Comparator for the treatment of Cystic Fibrosis
Arkansas
Site Reference ID/Investigator# 79265
Little Rock Arkansas 72202
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Site Reference ID/Investigator# 76785
Little Rock Arkansas 72205
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Little Rock Arkansas
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Little Rock Arkansas 72205
Patients are needed to participate in a clinical research study evaluating KB001-A and Placebo Comparator for the treatment of Cystic Fibrosis
California
Fresno California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Site Reference ID/Investigator# 105039
La Jolla California 92037
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
University of California - San Diego
La Jolla California 92093Updated
A clinical trial to evaluate treatments using Aztreonam for Inhalation Solution (AZLI) and Placebo for patients with Cystic Fibrosis
La Jolla California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Site Reference ID/Investigator# 79237
Loma Linda California 92354
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
View More »
Loma Linda California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Long Beach California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Long Beach California 90806
Patients are needed to participate in a clinical research study evaluating KB001-A and Placebo Comparator for the treatment of Cystic Fibrosis
Site Reference ID/Investigator# 79235
Los Angeles California 90027
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Children's Hospital Los Angeles
Los Angeles California 90027Updated
A clinical trial to evaluate treatments using Aztreonam for Inhalation Solution (AZLI) and Placebo for patients with Cystic Fibrosis
Los Angeles California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Madera California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Site Reference ID/Investigator# 78899
Oakland California 94611
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Site Reference ID/Investigator# 79295
Oakland California 94609
A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis
Kaiser Permanente Medical Center
Oakland California 94611Updated
A clinical trial to evaluate treatments using Aztreonam for Inhalation Solution (AZLI) and Placebo for patients with Cystic Fibrosis
Oakland California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Oakland California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Vertex Investigational Site
Oakland California
A clinical trial to evaluate treatments using VX-661, VX-770, VX-661 placebo and VX-770 placebo for patients with Cystic Fibrosis
Oakland California 94611
Patients are needed to participate in a clinical research study evaluating KB001-A and Placebo Comparator for the treatment of Cystic Fibrosis
Orange California
A clinical trial to evaluate treatments using Ivacaftor, Lumacaftor, Ivacaftor Placebo and Lumacaftor Placebo for patients with Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Orange California 92868
Patients are needed to participate in a clinical research study evaluating KB001-A and Placebo Comparator for the treatment of Cystic Fibrosis
Stanford University
Palo Alto California 94304Updated
A clinical research study of N6022 and Normal saline for the treatment of Cystic Fibrosis
Palo Alto California
A clinical trial to evaluate treatments using ivacaftor for patients with Cystic Fibrosis
First 1 2 3 4 5 6 7 8 9 10 11 12 13 Last